59
Participants
Start Date
December 31, 2009
Primary Completion Date
July 17, 2013
Study Completion Date
September 26, 2017
ipilimumab
Excisional Biopsy - baseline Induction ipilimumab 10 mg/kg IV day 0, 21 - baseline and week 3 Complete lymph node dissection - week ≥ 6 Maintenance Ipilimumab 10 mg/kg IV - Days 63 (+28 days) and, 84 (+28 days) - (3 weeks apart, starting 2-4 weeks following definitive lymphadenectomy)
University of Pittsburgh Medical Center/University of Pittsburgh Cancer Institute, Pittsburgh
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Diwakar Davar
OTHER